Delivery Order SPE2DB20D2014-SPE2DB24FB26V

Award Date 3/7/24
Potential Completion Date 3/8/24
Potential Value $6.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The order is for the supply of Fosamax 70 mg tablets, a brand name pharmaceutical product, with a ceiling value of $1,690.74 and a performance period through April 15, 2024. This delivery order is issued under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp to provide a comprehensive range of...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the supply of FOSAMAX 70 MG TABLET UU 4S, a pharmaceutical product, with a potential value of $3,041.14 and a completion date of March 6, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,795.69 firm fixed-price contract is for the provision of Fosamax 70 mg tablets to support federal healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,276.57 firm fixed-price delivery order covers the supply of Fosamax 70 mg tablets, with a period of performance through March 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract, valued at $2,218.56, is for the supply of Fosamax 70 mg tablets. The order has a completion date of June 11, 2024. Amerisourcebergen holds two Indefinite Delivery Contracts (IDCs) with the government - one with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025, and...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is to provide FOSAMAX 70 mg tablets, a prescription medication, with a potential value of $1,703.60 and a completion date of February 2, 2024. Amerisourcebergen Drug Corp, as the prime contractor, is supplying these pharmaceutical products to support...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company. The $2,896.12 award is for the delivery of FOSAMAX 70 MG tablets to support military treatment programs and facilities. Amerisourcebergen Drug Corp is the prime contractor, and no set-aside designation was used. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen...
This is a delivery order contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of FOSAMAX 70 MG TABLET, a pharmaceutical product, and has a ceiling value of $8,494.60. The contract is a firm-fixed-price, delivery order contract with a period of performance through July 2, 2024. The award is not associated with a set-aside program, indicating...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,135.84, is for the delivery of Fosamax 70 mg tablets. It is a firm-fixed-price contract with a completion date of July 1, 2024. AmerisourceBergen Drug Corp is the prime contractor, and there is no indication of any set-aside designation for this contract. The contract is part of a...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract is for the delivery of the pharmaceutical product FOSAMAX 70 MG TABLET UU 4S to the DLA Troop Support Medical facilities. The potential value of this specific delivery order is $2,896.12, with a completion date of February 23, 2024. Amerisourcebergen Drug Corp holds...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FB26V
    Delivery Order

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of Fosamax 70 mg tablets with a potential value of $6,150.48 and a performance period through March 8, 2024. This award is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this specific delivery order.

Generated 6/6/24, 10:20 AM